MS2Compound: A User-Friendly Compound Identification Tool for LC-MS/MS-Based Metabolomics Data

被引:14
|
作者
Behera, Santosh Kumar [1 ]
Kasaragod, Sandeep [1 ]
Karthikkeyan, Gayathree [1 ]
Narayana Kotimoole, Chinmaya [1 ]
Raju, Rajesh [1 ]
Prasad, Thottethodi Subrahmanya Keshava [1 ]
Subbannayya, Yashwanth [1 ,2 ]
机构
[1] Yenepoya Deemed Univ, Yenepoya Res Ctr, Ctr Syst Biol & Mol Med, Univ Rd, Mangalore 575018, India
[2] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res CEMIR, Dept Clin & Mol Med IKOM, Trondheim, Norway
关键词
metabolomics; MS2Compound; bioinformatics; systems science; data analysis; computational biology; metabolite identification; MASS-SPECTROMETRY; METABOLITE IDENTIFICATION; TRIPHALA; PLATFORM; ANNOTATION; PREDICTION; LIBRARY; XCMS; HMDB;
D O I
10.1089/omi.2021.0051
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Metabolomics is a leading frontier of systems science and biomedical innovation. However, metabolite identification in mass spectrometry (MS)-based global metabolomics investigations remains a formidable challenge. Moreover, lack of comprehensive spectral databases hinders accurate identification of compounds in global MS-based metabolomics. Creating experiment-derived metabolite spectral libraries tailored to each experiment is labor-intensive. Therefore, predicted spectral libraries could serve as a better alternative. User-friendly tools are much needed, as the currently available metabolomic analysis tools do not offer adequate provision for users to create or choose context-specific databases. Here, we introduce the MS2Compound, a metabolite identification tool, which can be used to generate a custom database of predicted spectra using the Competitive Fragmentation Modeling-ID (CFM-ID) algorithm, and identify metabolites or compounds from the generated database. The database generator can create databases of the model/context/species used in the metabolomics study. The MS2Compound is also powered with mS-score, a scoring function for matching raw fragment spectra to a predicted spectra database. We demonstrated that mS-score is robust in par with dot product and hypergeometric score in identifying metabolites using benchmarking datasets. We evaluated and highlight here the unique features of the MS2Compound by a re-analysis of a publicly available metabolomic dataset (MassIVE id: MSV000086784) for a complex traditional drug formulation called Triphala. In conclusion, we believe that the omics systems science and biomedical research and innovation community in the field of metabolomics will find the MS2Compound as a user-friendly analysis tool of choice to accelerate future metabolomic analyses.
引用
收藏
页码:389 / 399
页数:11
相关论文
共 50 条
  • [41] Neuroprotective effects of Longxue Tongluo Capsule on ischemic stroke rats revealed by LC-MS/MS-based metabolomics approach
    Jing Sun
    Xianyang Chen
    Yongru Wang
    Yuelin Song
    Bo Pan
    Bei Fan
    Fengzhong Wang
    Xiaonan Chen
    Pengfei Tu
    Jiarui Han
    Huixia Huo
    Jun Li
    Chinese Herbal Medicines, 2023, (03) : 430 - 438
  • [42] Neuroprotective effects of Longxue Tongluo Capsule on ischemic stroke rats revealed by LC-MS/MS-based metabolomics approach
    Sun, Jing
    Chen, Xianyang
    Wang, Yongru
    Song, Yuelin
    Pan, Bo
    Fan, Bei
    Wang, Fengzhong
    Chen, Xiaonan
    Tu, Pengfei
    Han, Jiarui
    Huo, Huixia
    Li, Jun
    CHINESE HERBAL MEDICINES, 2023, 15 (03) : 430 - 438
  • [43] Determination of hexamethylene bisacetamide, an antineoplastic compound, in mouse and human plasma by LC-MS/MS
    Smith, Kerri M.
    Ketchart, Wannarasmi
    Zhou, Xiang
    Montano, Monica M.
    Xu, Yan
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2011, 879 (23): : 2206 - 2212
  • [44] LC-MS/MS Based Volatile Organic Compound Biomarkers Analysis for Early Detection of Lung Cancer
    Sani, Shuaibu Nazifi
    Zhou, Wei
    Ismail, Balarabe B.
    Zhang, Yongkui
    Chen, Zhijun
    Zhang, Binjie
    Bao, Changqian
    Zhang, Houde
    Wang, Xiaozhi
    CANCERS, 2023, 15 (04)
  • [45] LC-MS/MS-based metabolomics approach identified novel antioxidant flavonoids associated with drought tolerance in citrus species
    Rao, Muhammad Junaid
    Feng, Bihong
    Ahmad, Muhammad Husnain
    ul Qamar, Muhammad Tahir
    Aslam, Muhammad Zeshan
    Khalid, Muhammad Fasih
    Hussain, Sajjad
    Zhong, Ruimin
    Ali, Qurban
    Xu, Qiang
    Ma, Chongjian
    Wang, Lingqiang
    FRONTIERS IN PLANT SCIENCE, 2023, 14
  • [46] Neuroprotective effects of Longxue Tongluo Capsule on ischemic stroke rats revealed by LC-MS/MS-based metabolomics approach
    Jing Sun
    Xianyang Chen
    Yongru Wang
    Yuelin Song
    Bo Pan
    Bei Fan
    Fengzhong Wang
    Xiaonan Chen
    Pengfei Tu
    Jiarui Han
    Huixia Huo
    Jun Li
    Chinese Herbal Medicines, 2023, 15 (03) : 430 - 438
  • [47] LIQUID: an-open source software for identifying lipids in LC-MS/MS-based lipidomics data
    Kyle, Jennifer E.
    Crowell, Kevin L.
    Casey, Cameron P.
    Fujimoto, Grant M.
    Kim, Sangtae
    Dautel, Sydney E.
    Smith, Richard D.
    Payne, Samuel H.
    Metz, Thomas O.
    BIOINFORMATICS, 2017, 33 (11) : 1744 - 1746
  • [48] Metabolic Alterations in the Outer Membrane Vesicles of Patients with Alzheimer's Disease: An LC-MS/MS-based Metabolomics Analysis
    Wei, Shou-Chao
    Wei, Wei
    Peng, Wan-Juan
    Liu, Zhou
    Cai, Zhi-You
    Zhao, Bin
    CURRENT ALZHEIMER RESEARCH, 2019, 16 (13) : 1183 - 1195
  • [49] LC-MS/MS-based metabolomics approach revealed novel phytocompounds from sugarcane rind with promising pharmacological value
    Rao, Muhammad Junaid
    Duan, Mingzheng
    Wei, Xiaoshuang
    Zuo, Hou
    Ma, Li
    Tahir ul Qamar, Muhammad
    Li, Min
    Han, Shijian
    Hu, Lihua
    Wang, Lingqiang
    JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 2022, 102 (14) : 6632 - 6642
  • [50] Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases
    Cui, Liang
    Lu, Haitao
    Lee, Yie Hou
    MASS SPECTROMETRY REVIEWS, 2018, 37 (06) : 772 - 792